{"title":"Urinary creatinine estimation as an important analytical limitation of semi-quantitative albumin-to-creatinine ratio strip testing: a diagnostic accuracy study.","authors":"Piyawan Bunpo, Pharisa Nanthawong, Chananon Chomphusri, Waratchaya Ratchawat, Suwatsin Kittikunnathum, Cheewaporn Tanintheerakul, Rungnapa Peerakam","doi":"10.3389/fmedt.2026.1913468","DOIUrl":"https://doi.org/10.3389/fmedt.2026.1913468","url":null,"abstract":"<p><strong>Background: </strong>Albuminuria is a key biomarker for chronic kidney disease and cardiovascular risk. Point-of-care urine albumin-to-creatinine ratio (UACR) testing may improve access to chronic kidney disease screening. However, limited evidence is available regarding the agreement of the individual albumin and creatinine components of semi-quantitative UACR strip tests with quantitative laboratory measurements.</p><p><strong>Methods: </strong>We evaluated 400 spot urine specimens using the Dirui H13-Cr semi-quantitative UACR strip and compared results with quantitative immunoturbidimetric UACR measurement performed on a Roche Cobas c503 analyzer. Agreement was assessed using Cohen's kappa coefficients, including category-specific agreement according to the KDIGO A1, A2, A3 albuminuria categories, and diagnostic performance was evaluated using sensitivity, specificity, predictive values, likelihood ratios, and diagnostic odds ratio (DOR).</p><p><strong>Results: </strong>Agreement between strip-based and quantitative measurements was substantial for urinary albumin (<i>κ</i>=0.691; 95% CI, 0.632-0.751) but considerably lower for urinary creatinine (<i>κ</i>=0.377; 95% CI, 0.331-0.423). Despite this disparity, UACR classification demonstrated substantial agreement (<i>κ</i>=0.627; 95% CI, 0.541-0.714). The findings suggest that semi-quantitative creatinine estimation is the primary analytical determinant of UACR misclassification. For detection of abnormal albuminuria (UACR ≥30 mg/g), the strip achieved a sensitivity of 83.66% and specificity of 83.22%. The PPV was 89.96% and NPV was 73.91%. Category-specific analysis showed that 131 of 177 A2 specimens (74.0%) were classified as A2 by the strip, whereas 64 of 80 A3 specimens (80.0%) were classified as A2 rather than A3.</p><p><strong>Conclusion: </strong>The Dirui H13-Cr strip demonstrated acceptable performance for albuminuria screening. However, semi-quantitative urinary creatinine estimation represented an important analytical limitation affecting UACR classification accuracy. Future development of strip-based UACR technologies should prioritize improved creatinine measurement to enhance diagnostic performance.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"8 ","pages":"1913468"},"PeriodicalIF":4.6,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13755268/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149414252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Optogenetics in neurobiology and neurodegenerative disorders: from neural circuit mechanisms to precision neuromodulation.","authors":"V Singaravel","doi":"10.3389/fmedt.2026.1958917","DOIUrl":"https://doi.org/10.3389/fmedt.2026.1958917","url":null,"abstract":"<p><p>Neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis and stroke, are characterized by progressive neuronal dysfunction, synaptic impairment and neural circuit degeneration, leading to severe cognitive and motor deficits. Although considerable progress has been made in understanding their molecular pathology, the circuit level mechanisms driving disease onset and progression remain incompletely understood. Optogenetics, which combines microbial opsins, genetic engineering and optical stimulation, enables reversible, cell-specific control of neuronal activity with millisecond precision and has transformed neuroscience from observational analysis to causal investigation of neural circuits. This review summarizes recent advances in the molecular basis of optogenetics, microbial opsins, gene delivery strategies and optical stimulation technologies, together with their applications in basic neurobiology and neurodegenerative disease research. We discuss how optogenetics has advanced understanding of neural circuit organization, synaptic plasticity, memory, neurodevelopment, sleep regulation, protein aggregation, synaptic dysfunction, neuroinflammation, mitochondrial impairment, oxidative stress and regulated cell death. Although these studies have generated important mechanistic insights and demonstrated functional improvements in experimental models, translation into human therapies remains investigational due to challenges associated with gene delivery, long-term opsin expression, immune compatibility and optical accessibility. Emerging therapeutic strategies, including closed-loop neuromodulation, wireless photostimulation, artificial intelligence-assisted neural decoding, nanotechnology enabled light delivery and brain computer interfaces, are critically evaluated with emphasis on their current evidence status, translational challenges and limitations for clinical implementation. Collectively, optogenetics provides an unprecedented platform for deciphering disease mechanisms and evaluating circuit-based neuromodulation strategies, while continued technological and biological validation will determine its future role in precision therapies for neurodegenerative disorders.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"8 ","pages":"1958917"},"PeriodicalIF":4.6,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13755834/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149414251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aigerim Ismukhamedova, Anna Bakanova, Saule Belginova, Arkadiusz Gola, Aisat Khalimov
{"title":"Early radiology reports and ECG machine measurements do not measurably improve 30-day ICU mortality prediction from the first 6 h of the stay: a multimodal ablation with external validation of the structured EHR backbone.","authors":"Aigerim Ismukhamedova, Anna Bakanova, Saule Belginova, Arkadiusz Gola, Aisat Khalimov","doi":"10.3389/fmedt.2026.1902843","DOIUrl":"10.3389/fmedt.2026.1902843","url":null,"abstract":"<p><p>Whether electrocardiographic measurements and unstructured clinical notes add prognostic information to structured electronic health records for early ICU mortality prediction remains unresolved. We trained a modality-attention model on tabular EHR features, machine-derived ECG measurements, printed diagnostic statements, and biomedical language-model representations of notes, all drawn from the first 6 h after ICU admission. Within that window, the only usable text in MIMIC-IV is the radiology report, available for 19.6% of stays. The discharge summary is the only other free-text table, but in 98.6% of stays in which it was charted during the window, it was filed after the window had closed. Mortality was assessed at 48 h, 7 days, and 30 days after ICU admission, with 30 days as the primary endpoint. The 6-h window is the period from which the predictors are drawn, not the interval over which death is predicted. Post-window features, including total ICU length of stay, were excluded. The cohort comprised each adult's first ICU stay in MIMIC-IV v3.1 (65,366 stays), holding out 9,806 (30-day mortality 10.6%), without a minimum stay to avoid day-one survival conditioning. Five variants used five seeds per horizon. EHR-only AUROCs were 0.9371, 0.9106, and 0.8969. Adding ECG, text, or both produced no reliable improvement: at 30 days, every paired AUPRC difference included zero, and the largest gain compatible with the data, 0.0068, was of the order of the study's own training noise. These are confidence limits, not equivalence bounds. No defect was identified in the preprocessing checks performed on the ECG matrix, and the matrix's highest-ranked input still ranked 106th of 1,827. L2-penalized logistic regression reached 0.8844, and the matched architecture added 0.0126 AUROC (0.0083-0.0168). All learned models outperformed SOFA at 0.731 and SAPS-II at 0.793, with DeLong <i>p</i> below 10<sup>⁻⁵⁹</sup>. Transferred without retraining, the models reached AUROC 0.833 on HiRID, 0.774 on MC-MED, and 0.7268 on eICU-CRD; none of these cohorts supplied ECG or notes, so they tested the structured backbone with both extra modalities masked, and the HiRID and MC-MED 30-day outcomes are derived from length of stay. Mean calibration gaps concealed over-prediction up to 0.167 in the highest-risk decile. AUROC was 0.853 for individuals aged 80 or above; race-stratified AUROC remained 0.878-0.914 compared with 0.897 overall. These findings pertain to early radiology reports and ECG summaries within a 6-h window.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"8 ","pages":"1902843"},"PeriodicalIF":4.6,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13752055/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149396631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Allam Jaya Prakash, Herbert F Jelinek, Mohamed Atef
{"title":"Uncertainty-aware fourier-encoded attentive Bi-GRU for non-invasive blood glucose estimation from multimodal PPG and GSR signals.","authors":"Allam Jaya Prakash, Herbert F Jelinek, Mohamed Atef","doi":"10.3389/fmedt.2026.1979468","DOIUrl":"10.3389/fmedt.2026.1979468","url":null,"abstract":"<p><p>Noninvasive estimation of glucose from wearable physiological signals remains challenging because sensor-glucose relationships vary across individuals and point estimates do not convey reliability. This article presents an uncertainty-aware regression framework that combines photoplethysmography and galvanic skin response. Synchronized signal segments are transformed using deterministic harmonic Fourier features and processed by a dense projection, a bidirectional gated recurrent unit with additive attention, and a multilayer regressor. Training uses a composite objective comprising mean absolute error, input-gradient smoothness, and a soft constraint on standardized outputs, while Monte Carlo dropout estimates model uncertainty during inference. The framework was evaluated on PhysioCGM recordings from 10 adults with type 1 diabetes, with continuous glucose monitor measurements used as reference values. A random sample-wise 80/20 split yielded a mean absolute error of 3.09 mg/dL, a root mean-square error of 4.72 mg/dL, and a coefficient of determination of 0.960; 96.3% and 99.1% of predictions were located in Clarke Error Grid Zone A and Zones A+B, respectively. In contrast, ten-fold leave-one-subject-out evaluation yielded a mean absolute error of 16.75 mg/dL with a between-fold standard deviation of 0.44 mg/dL and substantially weaker agreement in the hypoglycemic range. These findings indicate strong within-cohort interpolation but limited generalization to unseen individuals and underrepresented glycemic extremes. Larger participant-disjoint studies and calibrated uncertainty estimates are required before clinical or wearable deployment.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"8 ","pages":"1979468"},"PeriodicalIF":4.6,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13752052/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149396633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Thermal products dominate FDA adverse-event reports for electrophysical agents.","authors":"Doğukan Kurç","doi":"10.3389/fmedt.2026.1993929","DOIUrl":"10.3389/fmedt.2026.1993929","url":null,"abstract":"<p><strong>Introduction: </strong>Electrophysical agents contribute to rehabilitation and symptom management through different forms of energy. Postmarket evaluation therefore requires device-specific interpretation of reported health effects and technical problems.</p><p><strong>Methods: </strong>This retrospective descriptive study examined how technology, product-line concentration and reporting patterns shaped FDA device reports received during 2016-2025. Thirty-one product categories were searched. Device identity and application were screened, coded health effects and device problems were classified using exact-term dictionaries, and their co-occurrence was summarized by report.</p><p><strong>Results: </strong>The main analysis included 4,934 reports. Passive thermal packs and powered heating pads contributed 83.0% of the cohort. ThermaCare alone accounted for 1,705 reports (34.6%) across multiple manufacturer labels. Cutaneous codes occurred in 2,786 reports (56.5%); cutaneous and use/instruction codes co-occurred in 737. Excluding the two dominant thermal families left 840 reports, with cutaneous codes in 44.8% and neurological or neuromuscular codes in 7.9%. Electrical stimulation, optical therapy and iontophoresis showed distinct profiles. Receipt-year distributions revealed product-specific clusters, while narrative examination identified mismatches between product category and the reported operating mode. The 11 death-coded reports were characterized by the reported circumstances and attribution.</p><p><strong>Discussion: </strong>These findings support surveillance organized around identifiable product lines, actual operating modes and linked clinical-device information. Such reporting can guide targeted investigation and revision of device instructions and risk controls alongside continuing evaluation of therapeutic benefit.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"8 ","pages":"1993929"},"PeriodicalIF":4.6,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13752072/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149396632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pál Tamás Szabó, Beáta Réka Vásárhelyi, Patrícia Lajkó, Mona Stankovic, Márta Fekete, Beáta Pintérné Sosity, Samuel Chovanec, Ágnes Karolina Bakk
{"title":"A mechanism-oriented immersive virtual reality intervention for psychological distress and helplessness-related processes in hospitalized older adults: study protocol for a multicenter randomized controlled trial.","authors":"Pál Tamás Szabó, Beáta Réka Vásárhelyi, Patrícia Lajkó, Mona Stankovic, Márta Fekete, Beáta Pintérné Sosity, Samuel Chovanec, Ágnes Karolina Bakk","doi":"10.3389/fmedt.2026.1940940","DOIUrl":"10.3389/fmedt.2026.1940940","url":null,"abstract":"<p><strong>Background: </strong>Prolonged hospitalization in older adults may contribute to reduced autonomy, passivity, diminished perceived control, and psychological distress. Although hospitalization does not necessarily lead to learned helplessness, it may create conditions that increase vulnerability to helplessness-related processes in some patients, particularly when opportunities for self-directed action and visible action-outcome contingencies are limited. Immersive virtual reality (VR) may offer opportunities for safe, accessible, and meaningful interaction in otherwise constrained hospital environments; however, the added value of interactive, agency-supporting VR components remains insufficiently studied in hospitalized older adults.</p><p><strong>Objective: </strong>This study aims to evaluate the effectiveness of Zenctuary VR+, a mechanism-oriented, nature-based immersive VR intervention, in reducing psychological distress among hospitalized older adults compared with a passive VR control condition. Secondary aims are to explore changes in helplessness-related constructs, including self-efficacy, self-esteem, hopelessness, depressive symptoms, and learned helplessness.</p><p><strong>Methods and analysis: </strong>This is a multicenter, parallel-group, assessor-blinded randomized controlled trial conducted in inpatient hospital settings in Hungary. A total of 100 hospitalized adults aged 60 years or older will be randomly assigned in a 1:1 ratio to either the active Zenctuary VR+ intervention or a passive VR control condition. Both groups will receive six VR sessions over three weeks, delivered twice weekly using the same head-mounted display and the same nature-based virtual environments. The active intervention includes optional low-cognitive-load interactive activities designed to support agency, perceived control, and successful action, whereas the control condition involves passive observation of the same virtual environments without interactive elements. Assessments will be conducted at baseline, post-intervention, and four-week follow-up. The primary outcome is psychological distress measured by the Hospital Anxiety and Depression Scale total score. The primary analysis will use a linear mixed model to examine group-by-time effects. Secondary and mechanism-related analyses will be considered exploratory.</p><p><strong>Ethics and dissemination: </strong>The study has received national ethical and regulatory approval in Hungary from the National Centre for Public Health and Pharmacy. The trial has been registered at ClinicalTrials.gov (NCT07712549). Results will be disseminated through peer-reviewed publications, conference presentations, and project-related dissemination activities.</p><p><strong>Clinical trial registration: </strong>https://clinicaltrials.gov/study/NCT07712549, ClinicalTrials.gov: NCT07712549.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"8 ","pages":"1940940"},"PeriodicalIF":4.6,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13745731/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149382401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effects of chronic ankle instability on ipsilateral knee cartilage degeneration in mouse model.","authors":"Zhi Chen, Fanglu Xu, Bingqian Chen, Zhengfei Wang, Xiaohong Qu, Yao Fu, Jia Yu, Hongtao Zhang","doi":"10.3389/fmedt.2026.1854284","DOIUrl":"10.3389/fmedt.2026.1854284","url":null,"abstract":"<p><strong>Objective: </strong>To explore the effects of chronic ankle instability (CAI) on ipsilateral knee cartilage degeneration and the coupling relationship between the two joints through mouse model.</p><p><strong>Methods: </strong>Thirty C57BL/6J mice were divided into the Sham group, the CAI group, and the destabilization of medial meniscus (DMM) group. They were respectively subjected to sham surgery, anterior talofibular ligament and calcaneofibular ligament transection, and medial meniscus resection. The degeneration of knee cartilage was evaluated through kinematic experiments, imaging examinations and histopathological analysis within 12 weeks post-operation.</p><p><strong>Results: </strong>The kinematic experiments exhibited significantly increased passing time and number of slips for CAI group compared to DMM group and Sham group during crossing the balance beam; the step length and step width of CAI group were also larger. Imaging examination revealed obvious osteochondral defects and osteosclerosis of the femoral condyles both in CAI group and DMM group at 12 weeks post-operation. However, the DMM group was more severely affected than CAI group, as its bone mineral density and bone volume fraction were both higher than CAI group. Histopathological analysis exhibited thinner cartilage layer, less chondrocytes and more disordered collagen fibers in DMM group than CAI group at 6 and 12 weeks post-operation. The modified Mankin score and OARSI score of DMM group were also significantly higher than CAI group, while both groups were higher than Sham group.</p><p><strong>Conclusions: </strong>CAI can cause cartilage degeneration of ipsilateral knee joint in mouse model, there is a coupling relationship between ankle joint and knee joint.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"8 ","pages":"1854284"},"PeriodicalIF":4.6,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13745472/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149382402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Evaristus A Nwulia, Hasan Ali, Maria Mañanita S Hipolito, Narayan Rai, Santosh Venkatesha, John Collins, Penny Ford Carleton
{"title":"A GAITS-driven gap-to-deliverable accelerator for early-stage neurotechnology: design and early outcomes of the blueprint MedTech seedling program.","authors":"Evaristus A Nwulia, Hasan Ali, Maria Mañanita S Hipolito, Narayan Rai, Santosh Venkatesha, John Collins, Penny Ford Carleton","doi":"10.3389/fmedt.2026.1925746","DOIUrl":"10.3389/fmedt.2026.1925746","url":null,"abstract":"<p><strong>Background: </strong>Early-stage neurotechnology teams face a persistent structural barrier between scientific proof-of-concept and clinical/commercial viability. Traditional funding mechanisms, including investigator-initiated grants and early-stage SBIR/STTR awards, prioritize scientific novelty but may not address regulatory, clinical, market, and business challenges required for translation. Programs such as I-Corps and C3i improve commercialization literacy but primarily function as educational interventions. The NIH Blueprint MedTech (BPMT) Seedling Program addresses this gap by converting reviewer-identified commercialization weaknesses into structured, time-bounded work packages aligned with the Guidance and Impact Tracking System (GAITS), a commercialization maturity framework, and supported by experienced mentors.</p><p><strong>Objective: </strong>To describe the GAITS-driven Gap-to-Deliverable (G2G) acceleration model and characterize early program outcomes among neurotechnology teams participating in the BPMT Seedling Program.</p><p><strong>Methods: </strong>The six-month, mentor-centered Seedling Program operates within two NIH-funded neurotechnology incubator hubs: the Center for Innovative NeuroTech Advancement (CINTA) and NeuroTech Harbor (<i>N</i>TH). Each selected team receives $50,000 to address reviewer-identified commercialization gaps. Following multidisciplinary review, weaknesses are mapped to GAITS maturity indicators across Technology, Regulatory, Market/Business, and Clinical domains and converted into evidence-generating Work Packages. This descriptive program evaluation analyzed gap distributions across three cohorts (<i>N</i> = 58) and Deep Dive progression outcomes for two completed cohorts (<i>N</i> = 39).</p><p><strong>Results: </strong>GAITS-based review identified frequent commercialization gaps at program entry. Across all 58 teams, gaps were identified in team composition for 48/58 (82.8%), commercialization strategy for 47/58 (81.0%), work planning for 38/58 (65.5%), and regulatory strategy for 33/58 (56.9%). Among the two completed cohorts, 13/17 teams (76.5%; exact 95% CI, 50.1%-93.2%) in Cohort 1 and 18/22 teams (81.8%; 95% CI, 59.7%-94.8%) in Cohort 2 advanced to Blueprint MedTech Deep Dive evaluation; the combined progression rate was 31/39 (79.5%; 95% CI, 63.5%-90.7%). Cohort-specific rates did not differ statistically (Fisher exact <i>p</i> = 0.709).</p><p><strong>Conclusion: </strong>Among pre-screened teams with scientific or technical merit and addressable commercialization gaps, most advanced to internal Deep Dive evaluation after completing GAITS-aligned Work Packages. However, this uncontrolled evaluation of a selected cohort and program-specific endpoint does not establish causality or improved translational readiness. Prospective studies should incorporate standardized pre/post maturity measures, external downstream outcomes, and appropriate comparison groups to evaluate program effe","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"8 ","pages":"1925746"},"PeriodicalIF":4.6,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13736719/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149345213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A technical review of dynamic brain functional imaging combined with EEG spectral parameters in the screening of early-stage brain injury.","authors":"Hongmei Ruan, Liqing Liao, Yuan Zhang, Zicai Liu, Qiang Wu","doi":"10.3389/fmedt.2026.1960562","DOIUrl":"https://doi.org/10.3389/fmedt.2026.1960562","url":null,"abstract":"<p><strong>Background: </strong>Early-stage brain injury encompasses subtypes such as mild traumatic brain injury (mTBI), silent stroke and subclinical brain injury. It is characterised by negative imaging findings, subtle symptoms and a high risk of long-term neurological deficits, presenting a key challenge in the early screening and prevention of neurological diseases. Traditional imaging techniques, such as structural Magnetic Resonance Imaging (MRI) and Computed Tomography (CT), can only identify organic morphological lesions. Their detection rate for early micro-injuries at the level of neuronal electrophysiology and brain network function is extremely low. Consequently, these techniques struggle to meet the clinical needs for early screening, assessment, and intervention.</p><p><strong>Methods: </strong>Electroencephalography (EEG) spectral changes (including conventional spectral slowing and 1/f aperiodic abnormalities) and large-scale dynamic neural network disruption across the entire brain are core pathological features of early brain functional damage; they may serve as indirect correlates of microscopic pathological changes such as an imbalance in neuronal excitation-inhibition and abnormalities in the efficiency of brain information transmission. Based on this, this paper proposes a Dynamic-Spectral Coupling (DSC) framework, which proposes spectral abnormalities as a potential upstream mechanism associated with network reorganisation. Within this framework, this narrative review summarizes dynamic functional magnetic resonance imaging (dynamic fMRI), EEG spectral analysis and multimodal fusion technologies, with a particular focus on elucidating the coupling mechanisms between EEG periodic and 1/f aperiodic spectral parameters and dynamic brain network indicators.</p><p><strong>Results: </strong>The review outlines the screening value and application advantages of multimodal fusion technologies in mTBI, occult cerebrovascular injury and subclinical brain injury. Furthermore, the paper summarises the current limitations of these technologies in terms of clinical translation, methodology and database development.</p><p><strong>Conclusions: </strong>Taking into account the clinical needs of neurorehabilitation, it proposes future development directions, including the development of lightweight devices, AI-assisted diagnosis, the establishment of standardised analytical systems and the translation of precision rehabilitation. The aim is to provide technical guidance and theoretical support for screening, risk stratification and rehabilitation planning in early-stage brain injury, while acknowledging that clinical utility remains to be established.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"8 ","pages":"1960562"},"PeriodicalIF":4.6,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13720356/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149328998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Leonhard Stein, Lukas Gschoßmann, Mareike Barthel, Sebastian Dendorfer
{"title":"Inter-system reliability of markerless motion capture in older hip and knee patients during walking.","authors":"Leonhard Stein, Lukas Gschoßmann, Mareike Barthel, Sebastian Dendorfer","doi":"10.3389/fmedt.2026.1940851","DOIUrl":"https://doi.org/10.3389/fmedt.2026.1940851","url":null,"abstract":"<p><p>This study evaluated the inter-system reliability of multi-camera markerless motion capture (MMC) during walking in older adults with hip or knee pathology and compared inter-system disagreement with a healthy control group. Forty-one participants were included: 15 hip patients, 13 knee patients, and 13 healthy controls. All participants performed walking trials recorded simultaneously by two temporally aligned MMC systems. Inter-system consistency was assessed using waveform-based comparison of joint angle trajectories across the gait cycle and discrete range of motion parameters. Waveform disagreement was quantified using one-dimensional statistical parametric mapping and root-mean-square error, while discrete outcomes were evaluated using intraclass correlation coefficient (ICC), standard error of measurement (SEM), minimal detectable change at the 95% confidence level, and Bland-Altman metrics. Group differences in subject-level inter-system disagreement metrics were tested using linear models. ICC-based inter-system reliability was predominantly high, with 18 of 36 parameters classified as excellent, 10 good, 6 moderate, and 2 poor. SEM values were below <math><msup><mn>2</mn> <mo>∘</mo></msup> </math> for most parameters. The least robust results were consistently observed for trunk flexion and selected transverse-plane variables. Exploratory group comparisons did not reveal a consistent directional pattern of increased disagreement in the pathological groups, and clinically plausible group differences were similarly reflected by both systems. However, the modest group sizes limit the ability to exclude smaller pathology-related effects on measurement consistency. These findings indicate small within-platform inter-system disagreement in most lower-limb outcomes for gait analysis in older adults with hip or knee pathology. Trunk and some transverse-plane outputs should be interpreted with greater caution.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"8 ","pages":"1940851"},"PeriodicalIF":4.6,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13716743/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149303214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}